The screened candidates, as the targets of miR-21 and miR-21*, included a large number of oncogenic proteins and tumour suppressors, such as Ras, GRHL3, CHL1, PDCD4, PTEN, RECK and HNRPK (S2 Table). The gene discussed is HNRNPK; the disease is neoplasm.